Innovating Works

IDRI

STriTuVaD: In Silico Trial for Tuberculosis Vaccine Development INFECTIOUS DISEASE RESEARCH INSTITUTE participó en un H2020 H2020-SC1-2016-2017 Tuberculosis (TB) one of the world’s deadliest diseases: one third of the world’s population, mostly in developing countries, is infected wi...
2017-11-13 - 2023-01-31 | financed
ADITEC: Advanced Immunization Technologies INFECTIOUS DISEASE RESEARCH INSTITUTE participó en un FP7 Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious...
financed
MULEVACLIN: Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis INFECTIOUS DISEASE RESEARCH INSTITUTE participó en un FP7 The World Health Organisation in its report on Neglected Tropical Diseases has stated that there is overwhelming evidence to show that the b...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.